ArticleThe pathogenesis of cytokines in preportal fibrosis of human infected with schistosomiasis and viral hepatitis
ArticleThe pathogenesis of cytokines in preportal fibrosis of human infected with schistosomiasis and viral hepatitis
ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleROLE OF INTERLEUKIN-17 IN THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HEPATITIS C VIRUS LIVER CIRRHOSIS
ArticleInterleukin-9: Investigating its possible role in liver cirrhosis progression and in tumour promotion of hepatocellular carcinoma in chronic HCV infected patients, A single centre study
ArticleInterleukin-9: Investigating its possible role in liver cirrhosis progression and in tumour promotion of hepatocellular carcinoma in chronic HCV infected patients, A single centre study
ArticleRole of Serum Interleukin–10 as a Marker of T-helper 2 Activity in Egyptian Chronic Hepatitis C Patients
ArticleRole of Serum Interleukin–10 as a Marker of T-helper 2 Activity in Egyptian Chronic Hepatitis C Patients
ArticleIN VIVO AND IN VITRO EXPRESSIONS OF CCR1 AND CCR5 IN PATIENTS WITH ACTIVE SCHISTOSOMIASIS AND CHRONIC LIVER DISEASE
ArticleIN VIVO AND IN VITRO EXPRESSIONS OF CCR1 AND CCR5 IN PATIENTS WITH ACTIVE SCHISTOSOMIASIS AND CHRONIC LIVER DISEASE
ArticleSCHSITOSOMA MANSONI CO-INFECTION WITH HEPATITIS C VIRUS IS ASSOCIATED WITH INCREASED INTERLEUKIN-28B PLASMA LEVELS IN EGYPTIAN POPULATION
ArticleSCHSITOSOMA MANSONI CO-INFECTION WITH HEPATITIS C VIRUS IS ASSOCIATED WITH INCREASED INTERLEUKIN-28B PLASMA LEVELS IN EGYPTIAN POPULATION
ArticleThe Role of Interleukin-10 Gene Polymorphism in Egyptian Patients with Chronic Hepatitis C Virus
ArticleThe Role of Interleukin-10 Gene Polymorphism in Egyptian Patients with Chronic Hepatitis C Virus
ArticleEffect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients
ArticleEffect of hepatitis C virus infection on the circulating levels of interleukin (IL)-22, IL-32 and IL-34 in non-Hodgkin lymphoma patients